Journal of Translational Neurosciences

Covid-19 Associated Guillain-Barre Syndrome:a Case Report

Acute inflammatory demyelinating polyneuropathy (AIDP) is a sub type of Guillain–Barré syndrome that occurs after the viral and bacterial infections. In the literature a few data are represented on AIDP cases related with Coronavirus-2 (Sars-Cov-2) infections. [1] In this study; a male patient, aged 35 without a known disease is represented. Two weeks before the initial occurrence of typical clinical and electrophysiological AIDP symptoms, the real-time polymerase chain reaction (PCR) test of oropharyngeal swab samples has resulted Covid-19 positive on the patient. The weakness and loss of sensation are observed starting from the lower extremities and continuing along the upper extremities after the remission of respiratory and fever symptoms of the patient in question. Therefore, the patient is diagnosed with segmental demyelinating polyneuropathy by electrophysiological evaluation on the first day of the hospitalisation, following that albuminocytological dissociation is observed by the cerebrospinal fluid (CSF) examination. The remission of symptoms is reported within five-days of intravenous immunoglobin (IVIG) treatment. This study makes difference in the literature by pointing a young patient without underlying chronic medical conditions.

Author(s):

Bünyamin TosunoÄ?lu1*,Burcu Gökçe Çokal1, Tahir KurtuluÅ? YoldaÅ?1, Olcay Tosun Meric2

Abstract | Full-Text | PDF

Share this